Concurrent mutations in STK11 and KEAP1 promote ferroptosis protection and SCD1 dependence in lung cancer CA Wohlhieter, AL Richards, F Uddin, CH Hulton, À Quintanal-Villalonga, ... Cell reports 33 (9), 2020 | 138 | 2020 |
A Genomic-Pathologic Annotated Risk Model to Predict Recurrence in Early-Stage Lung Adenocarcinoma GD Jones, WS Brandt, R Shen, et al. JAMA Surgery, 2020 | 57 | 2020 |
Harnessing clinical sequencing data for survival stratification of patients with metastatic lung adenocarcinomas R Shen, A Martin, A Ni, M Hellmann, KC Arbour, E Jordan, A Arora, ... JCO precision oncology 3, 1-9, 2019 | 36 | 2019 |
Implications of selection bias due to delayed study entry in clinical genomic studies S Brown, JA Lavery, R Shen, AS Martin, KL Kehl, SM Sweeney, ... JAMA oncology 8 (2), 287-291, 2022 | 31 | 2022 |
The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: a retrospective study MG Zauderer, A Martin, J Egger, H Rizvi, M Offin, A Rimner, PS Adusumilli, ... The Lancet Digital Health 3 (9), e565-e576, 2021 | 30 | 2021 |
Rb and p53-deficient myxofibrosarcoma and undifferentiated pleomorphic sarcoma require Skp2 for survival GZ Li, T Okada, YM Kim, NP Agaram, F Sanchez-Vega, Y Shen, ... Cancer research 80 (12), 2461-2471, 2020 | 26 | 2020 |
Genetic variants and cognitive functions in patients with brain tumors DD Correa, J Satagopan, A Martin, E Braun, M Kryza-Lacombe, ... Neuro-oncology 21 (10), 1297-1309, 2019 | 25 | 2019 |
Correlation between surrogate end points and overall survival in a multi-institutional clinicogenomic cohort of patients with non–small cell lung or colorectal cancer KL Kehl, GJ Riely, EM Lepisto, JA Lavery, JL Warner, ML LeNoue-Newton, ... JAMA Network Open 4 (7), e2117547-e2117547, 2021 | 19 | 2021 |
Analysis of the canid Y-chromosome phylogeny using short-read sequencing data reveals the presence of distinct haplogroups among Neolithic European dogs MT Oetjens, A Martin, KR Veeramah, JM Kidd BMC genomics 19, 1-9, 2018 | 19 | 2018 |
Mining mutation contexts across the cancer genome to map tumor site of origin S Chakraborty, A Martin, Z Guan, CB Begg, R Shen Nature Communications 12 (1), 3051, 2021 | 12 | 2021 |
Bioinformatically Expanded Next-Generation Sequencing Analysis Optimizes Identification of Therapeutically Relevant MET Copy Number Alterations in >50,000 … JP Solomon, SR Yang, NJ Choudhury, RN Ptashkin, N Eslamdoost, ... Clinical Cancer Research 28 (21), 4649-4659, 2022 | 10 | 2022 |
Fair generalized linear models with a convex penalty H Do, P Putzel, AS Martin, P Smyth, J Zhong International Conference on Machine Learning, 5286-5308, 2022 | 8 | 2022 |
Concurrent mutations in STK11 and KEAP1 promote ferroptosis protection and SCD1 dependence in lung cancer. Cell Rep. 33, 108444 CA Wohlhieter, AL Richards, F Uddin, CH Hulton, A Quintanal-Villalonga, ... | 8 | 2020 |
Genomic Determinants of Early Recurrences in Low-Stage, Low-Grade Endometrioid Endometrial Carcinoma NS Safdar, M Stasenko, P Selenica, AS Martin, EM da Silva, ... JNCI: Journal of the National Cancer Institute 114 (11), 1545-1548, 2022 | 7 | 2022 |
A data processing pipeline for the AACR project GENIE biopharma collaborative data with the {genieBPC} R package JA Lavery, S Brown, MA Curry, A Martin, DD Sjoberg, K Whiting Bioinformatics 39 (1), btac796, 2023 | 3 | 2023 |
Clinical reliability of genomic data obtained from spinal metastatic tumor samples O Barzilai, A Martin, AS Reiner, I Laufer, A Schmitt, MH Bilsky Neuro-oncology 24 (7), 1090-1100, 2022 | 3 | 2022 |
Identifying prognostic pairwise relationships among bacterial species in microbiome studies SM Devlin, A Martin, I Ostrovnaya PLOS Computational Biology 17 (11), e1009501, 2021 | 2 | 2021 |
Automated annotation for large-scale clinicogenomic models of lung cancer treatment response and overall survival J Jee, C Fong, K Pichotta, T Tran, A Luthra, M Altoe, S Maron, R Shen, ... Cancer Research 83 (7_Supplement), 5721-5721, 2023 | | 2023 |
Evaluating the association between clonal hematopoiesis and germline pathogenic and likely pathogenic variants in cancer predisposition genes. EA Comen, P Razavi, PB Patel, A Martin, VE Seshan, D Mandelker, ... Journal of Clinical Oncology 38 (15_suppl), 1535-1535, 2020 | | 2020 |
Abstract LB-304: Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis K Bolton, R Ptashkin, L Braunstein, T Gao, SM Devlin, D Kelly, C Coombs, ... Cancer Research 79 (13_Supplement), LB-304-LB-304, 2019 | | 2019 |